当前位置:首页 > 科研成果 > 本所论文
论文题目: Placenta-derived gp96 as a multivalent prophylactic cancer vaccine
作者: Zhao Bao, Wang Yanzhong, Wu Bo, Liu Shan, Wu Erjie, Fan HongXia, Gui MingMing, Chen Lizhao, Li Changfei, Ju Ying, Zhang Wei & Meng Songdong
联系作者: Meng Songdong
刊物名称: Scientific Reports 3
期:
卷:
页:
年份: 2013
影响因子: 0
论文下载: http://www.nature.com/srep/2013/130606/srep01947/full/srep01947.html#affil-auth
摘要: A major challenge for designing prophylactic cancer vaccines is to define immunogenic and safe cancer antigens. Given the striking similarity of antigen expression patterns between cancer and embryonic tissues, we defined a prototype strategy of using placenta-derived heat shock protein gp96, which induces prophylactic anti-tumor T cell responses. Immunization with placental gp96 provided partial protection and long-term (at least 3 months) anti-tumor immunity against growth of transplantable melanoma or breast tumors in mice, elicited total protection against 7, 12-dimethylbenz(a)-anthracene (DMBA)-induced mammary tumors in rats, and significantly reduced the occurrence and growth of autochthonous breast tumors in HER2 transgenic mice. Placental gp96 activated HER2- and MUC1-specific T cell responses through binding to tumor-associated antigens. Our results reveal the novel immunogenicity of placental gp96 and its potential use as a multivalent cancer vaccine.